Synopsys
$489.90Change from previous close: −0.13%Absolute change: −$0.64
At a glance
- Revenue growth
- +15.12%
- FY to Oct 2025 vs FY to Oct 2024
- Net income growth
- −41.14%
- FY to Oct 2025 vs FY to Oct 2024
- Net margin
- 18.9%
- FY to Oct 2024: 36.9%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q to Jul 2026 | Q to Apr 2026 | Q to Jan 2026 | Q to Oct 2025 | Q to Jul 2025 | Q to Apr 2025 | Q to Jan 2025 | Q to Oct 2024 | Q to Jul 2024 | Q to Apr 2024 | Q to Jan 2024 | Q to Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 813 | 629 | 857 | 640 | 671 | 275 | -67.5 | 563 | 455 | 477 | -87.8 | 326 |
| Depreciation and amortization | 262 | 263 | 257 | 255 | 77.1 | 41.6 | 39.7 | 48.5 | 42.8 | 59.2 | 39.8 | 52.5 |
| Capital expenditure | -66.6 | -54.2 | -35.3 | -34.5 | -38.6 | -55.6 | -40.7 | -20.7 | -40.0 | -38.4 | -40.4 | -53.1 |
| Investing cash flow | 443 | -52.9 | -36.5 | 564 | -16,500 | 76.0 | -22.0 | 1,443 | -53.8 | -112 | -54.4 | -301 |
| Financing cash flow | -37.8 | -281 | -1,583 | -836 | 4,237 | 10,096 | -142 | 30.1 | -56.8 | 32.6 | -187 | -254 |
| Share repurchases | -82.4 | -336 | -145 | -62.7 | -75.9 | -41.9 | -125 | -59.0 | -66.0 | -65.2 | -147 | -342 |
| Debt issued | 0.0 | — | — | 0.0 | 4,295 | 10,034 | — | — | — | — | — | — |
| Debt repaid | -1.4 | -11.1 | -3,451 | -861 | -1.3 | — | -1.3 | -72.3 | 53.4 | -6.7 | -49.3 | — |
| Effect of exchange rates | -24.2 | -12.7 | 3.4 | -6.8 | 0.5 | 17.9 | -9.7 | 3.3 | 3.0 | -6.9 | 9.3 | -18.0 |
| Net change in cash | 1,194 | 282 | -759 | 362 | -11,591 | 10,466 | -241 | 2,039 | 348 | 390 | -320 | -247 |
| Free cash flow | 746 | 575 | 822 | 605 | 632 | 220 | -108 | 542 | 415 | 438 | -128 | 273 |
| Levered free cash flow | 890 | 778 | 901 | 856 | 1,004 | 335 | -24.0 | 1,280 | 310 | -566 | -224 | 272 |